CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has announced the completion of an evaluation of a commercial PCR test, its MycAssayTM Aspergillus assay, to detect invasive Aspergillosis (IA) in a mixed population of 158 patients with underlying haematological or critical illness. The prospective evaluation was performed by Professor Sanguinetti’s team at the Institute of Microbiology in Rome and the results of the study are published in the US Journal of Clinical Microbiology [Torelli R et al. J Clin Microbiol. 2011 Oct 19. [Epub ahead of print].
